Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "PWNHealth"


2 mentions found


A biotech company said 400 people had been mistakenly informed they might have cancer. Grail Inc said the error resulted from a software issue, which has been resolved. The incident was part of a trial of an early-detection blood test called Galleri. Grail Inc, an American biotechnology company, developed an early-detection blood test called Galleri, created to identify more than 50 types of cancer before symptoms appear, per Reuters. The company, owned by gene sequencing company Illumina, said it promptly contacted patients after the incident.
Persons: , Grail, PWNHealth, MassMutual Organizations: Inc, Service, Financial Times, British Locations: American
Companies Grail Inc FollowIllumina Inc FollowJune 2 (Reuters) - Cancer test maker Grail Inc (GRAL.O) said on Friday that its telemedicine vendor erroneously sent letters to about 400 patients suggesting they may have developed cancer. Grail's flagship cancer detection blood test Galleri is designed to detect more than 50 types of cancer before symptoms appear. Grail said it had reached out to the patients immediately after the issue, adding that no patient health information has been disclosed or breached due to this. The software issue being faced by PWNHealth has now been resolved, it said. Illumina is currently appealing regulatory orders in the U.S. and EU, which are asking the gene sequencing company to divest Grail after it jumped regulators to close its acquisition of the cancer test maker.
Persons: Grail, PWNHealth, Illumina, Mariam Sunny, Shilpi Majumdar Organizations: Illumina Inc, Thomson Locations: U.S, Bengaluru
Total: 2